The Pharmacy and Poisons Board (PPB) has announced the voluntary recall of S-PRAZO (Esomeprazole Magnesium Delayed-Release Capsules 40mg), Batch No SPZ-302 Manufactured by Laborate Pharmaceutical India Limited.
PPB Chief Executive Officer, Dr. Fred Siyoi, said that the product batch is being recalled following a market complaint regarding the mix-up of blister strips, where some boxes were found to contain two different blister strips, that is, S-Prazo capsules and Donystatin tablets, within the same outer carton.
“In view of the above, the Board advises all pharmaceutical outlets, healthcare facilities, healthcare professionals, and members of the public to stop further distribution, sale, issuing, or use of the product batch and return the specified product batch to their nearest healthcare facility or respective suppliers,” said Dr. Siyoi.
He affirmed that the Board remains committed to protecting the health of the public and encourages the public to promptly report any suspected cases of substandard medicines or adverse drug reactions.
“The reports may be made to the nearest healthcare facility or the Pharmacy and Poisons Board through our channels, which are: website: https://pv.pharmacyboardkenya.org/users/mpublic, USSD code: *271#, mobile application: mPVERS both Android and iOS, email: pms@ppb.go.ke or pv@ppb.go.ke, and telephone no. 0795 743 049,” said Dr. Siyoi.
By Joseph Ng’ang’a
